Animal models of movement disorders

Susan Duty, Peter Jenner*

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review


Animal models of movement disorders have been invaluable in unravelling the pathological basis of human disease and in the search for novel effective therapies that address the unmet medical needs in the treatment of symptoms and provision of disease-modifying approaches. Using the examples of toxin-based approaches and genetic manipulation, we describe the use of animal models to explore both common and rare movement disorders that are either drug induced or are sporadic or familial in expression and that either have well-defined pathology or appear to reflect more general changes in neurotransmission and brain circuitry. Parkinson’s disease and Huntington’s disease form a focus as largely basal ganglia disorders, with more complex disorders including multiple system atrophy, progressive supranuclear palsy and dystonia explored alongside amyotrophic lateral sclerosis. The conclusion reached is that whilst current animal models have proved essential for improving knowledge of the pathogenesis of movement disorders, much remains to be done to exploit them for the development of novel therapeutic strategies to be explored in man.

Original languageEnglish
Title of host publicationMovement Disorders Curricula
PublisherSpringer-Verlag Wien
Number of pages11
ISBN (Electronic)9783709116289
ISBN (Print)9783709116272
Publication statusPublished - 1 Jan 2017


  • Amyotrophic lateral sclerosis
  • Dyskinesia
  • Dystonia
  • Huntington’s disease
  • Multiple system atrophy
  • Parkinson’s disease
  • Progressive supranuclear palsy
  • Toxin-based models
  • Transgenic models


Dive into the research topics of 'Animal models of movement disorders'. Together they form a unique fingerprint.

Cite this